- Home
- FGEN vs TURN Comparison
FGEN vs TURN Comparison
Compare FGEN & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- TURN
- Stock Information
- Founded
- FGEN 1993
- TURN 1981
- Country
- FGEN United States
- TURN United States
- Employees
- FGEN N/A
- TURN N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- TURN Finance/Investors Services
- Sector
- FGEN Health Care
- TURN Finance
- Exchange
- FGEN Nasdaq
- TURN Nasdaq
- Market Cap
- FGEN 33.5M
- TURN 38.3M
- IPO Year
- FGEN 2014
- TURN N/A
- Fundamental
- Price
- FGEN $0.31
- TURN $4.02
- Analyst Decision
- FGEN Strong Buy
- TURN
- Analyst Count
- FGEN 1
- TURN 0
- Target Price
- FGEN $10.00
- TURN N/A
- AVG Volume (30 Days)
- FGEN 514.9K
- TURN 42.4K
- Earning Date
- FGEN 05-12-2025
- TURN 05-20-2025
- Dividend Yield
- FGEN N/A
- TURN N/A
- EPS Growth
- FGEN N/A
- TURN N/A
- EPS
- FGEN N/A
- TURN N/A
- Revenue
- FGEN $29,621,000.00
- TURN $194,813.00
- Revenue This Year
- FGEN $232.81
- TURN N/A
- Revenue Next Year
- FGEN $9.16
- TURN N/A
- P/E Ratio
- FGEN N/A
- TURN N/A
- Revenue Growth
- FGEN N/A
- TURN 254.25
- 52 Week Low
- FGEN $0.18
- TURN $3.12
- 52 Week High
- FGEN $1.74
- TURN $4.23
- Technical
- Relative Strength Index (RSI)
- FGEN 46.75
- TURN 58.96
- Support Level
- FGEN $0.28
- TURN $3.68
- Resistance Level
- FGEN $0.34
- TURN $4.22
- Average True Range (ATR)
- FGEN 0.02
- TURN 0.31
- MACD
- FGEN 0.00
- TURN 0.02
- Stochastic Oscillator
- FGEN 37.50
- TURN 67.19
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.